Timber Pharmaceuticals Inc Business Update and Q&A Call Transcript
This meeting is being recorded.
Hi, I'm Jeff Ramson, CEO of PCG Advisory. Thank you for joining us for today's business briefing and Q&A with Timber Pharmaceuticals, trading on the New York Stock Exchange American under the symbol TMBR. With us today we have John Koconis, CEO of Timber, who will discuss the company's significant achievements during 2022, and we'll take a look at what investors can expect to see in 2023. (Operator Instructions)
I'll now turn the call over to John. John, please start with a brief presentation for those attendees who may not be familiar with Timber, and then we'll proceed to the Q&A segment. John, please go ahead.
Thank you very much, Jeff, and good morning to everybody and for everyone that's decided to spend some time here and listen to the Timber story. I will go through a quick presentation of Timber, and then I will do my best to answer all the questions that have
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investorsā 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |